Work

Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention

Year: 2014
Type: editorial
Abstract: Metabolic syndrome, also known as insulin resistance syndrome, has become a major public health problem worldwide.It consists of obesity, hyperglycemia, hyperinsulinemia, dyslipidemia, and hypertension.Metabolic syndrome is a major risk factor for the development of type 2 diabetes mellitus, which currently afflicts 22 million Americans and over 100 million Chinese (Alberti et al. 2005, Cornier et al. 2008, Roger et al. 2011).Importantly, metabolic syndrome is also a significant risk factor for the development of cardiovascular disease, and two-thirds of patients with diabetes mellitus die of heart failure (Roger et al. 2011).In 2011, an estimated 366 million people around the world had diabetes, and this number is predicted to rise to 522 million by 2030 (Whiting et al. 2011).The estimated costs of diagnosed diabetes in the USA have risen from $174 billion in 2007 to $245 billion in 2012 (Herman 2013).Obviously, understanding and controlling metabolic syndrome and associated cardiovascular disorders have far-reaching impacts on our healthcare and economic systems that affect the quality of our daily life.As a first step, understanding the mechanisms responsible for insulin action and resistance is critical for developing therapeutic interventions and, thereby controlling metabolic syndrome.In this special issue of Journal of Endocrinology, we provide four thematic review articles, which combine discussion of the disease mechanism behind metabolic syndrome with the most recent research from cell-based and animal studies.These reviews address how insulin resistance in different organs contributes to metabolic syndrome at the molecular, biochemical, and physiological levels.In particular,
Author: Shaodong Guo
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2061429720
Cites: 32
Cited by: 391
Related to: 10